Kesimpta Drug Interactions: 219 Major, 63 Moderate
Kesimpta (Ofatumumab) Drug Interactions
Check all documented drug-to-drug interactions. Major, moderate, and minor interactions with descriptions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Kesimpta. Always confirm against the full prescribing information.
100 interactions
Anthrax immune globulin human
The therapeutic efficacy of Anthrax immune globulin human can be decreased when used in combination with Ofatumumab.
Level 2 evidence
Articaine
The risk or severity of methemoglobinemia can be increased when Ofatumumab is combined with Articaine.
Level 1 evidence
AstraZeneca COVID-19 Vaccine
The therapeutic efficacy of AstraZeneca COVID-19 Vaccine can be decreased when used in combination with Ofatumumab.
Level 2 evidence
Benzocaine
The risk or severity of methemoglobinemia can be increased when Ofatumumab is combined with Benzocaine.
Level 1 evidence
Benzyl alcohol
The risk or severity of methemoglobinemia can be increased when Ofatumumab is combined with Benzyl alcohol.
The therapeutic efficacy of Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated) can be decreased when used in combination with Ofatumumab.
Level 2 evidence
Bupivacaine
The risk or severity of methemoglobinemia can be increased when Ofatumumab is combined with Bupivacaine.
Level 1 evidence
Butamben
The risk or severity of methemoglobinemia can be increased when Ofatumumab is combined with Butamben.
Level 1 evidence
Capsaicin
The risk or severity of methemoglobinemia can be increased when Ofatumumab is combined with Capsaicin.
Level 1 evidence
Chloroprocaine
The risk or severity of methemoglobinemia can be increased when Ofatumumab is combined with Chloroprocaine.
Level 1 evidence
Cinchocaine
The risk or severity of methemoglobinemia can be increased when Ofatumumab is combined with Cinchocaine.
Kesimpta (Ofatumumab) has 403 documented drug interactions. Always review the full list with a pharmacist before co-prescribing.
Kesimpta (Ofatumumab) has 219 major, 63 moderate, and 121 minor documented interactions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Kesimpta. Always confirm against the full prescribing information.